Anavex Life Sciences Corp (AVXL)

[Hosai]

For a somewhat negative article she also seems to suggest FDA could indeed approve Blarcamesine after the change in guidance but then also says that Anavex is fairly priced currently.
It's hard to see how these two beliefs can go together. If you gave a 50% chance of FDA approval which is the vibe she gives i.e calculated all the future revenues/profits etc from US/Europe/UK and then mutiplied the resultant market cap by 0.5 you are clearly going to have a far higher market cap than where it is now. Unless she really belives the take up would be very very limited but it's hard to see how considering the competition in the AD space and the ease of taking a pill etc.